v3.26.3
Financing (Narrative) (Details)
€ in Millions, SFr in Millions
9 Months Ended
Jun. 03, 2026
USD ($)
Jun. 03, 2026
CHF (SFr)
Apr. 23, 2026
USD ($)
Apr. 23, 2026
EUR (€)
Apr. 16, 2026
USD ($)
Sep. 25, 2026
USD ($)
Sep. 30, 2026
EUR (€)
Sep. 25, 2026
EUR (€)
Mar. 18, 2026
EUR (€)
Dec. 31, 2025
USD ($)
Dec. 31, 2025
EUR (€)
Debt Instrument [Line Items]                      
Debt discounts, premiums and debt issuance costs           $ 126,000,000       $ 93,000,000  
Borrowings outstanding           24,388,000,000       18,416,000,000  
Borrowings outstanding           26,482,000,000       18,418,000,000  
Multi-year Credit Facility | Revolving credit facility | Line of credit                      
Debt Instrument [Line Items]                      
Line of credit facility           5,000,000,000.0          
Borrowings outstanding           0          
Euro-denominated commercial paper                      
Debt Instrument [Line Items]                      
Borrowings outstanding           $ 4,700,000,000          
Euro-denominated commercial paper | Commercial paper                      
Debt Instrument [Line Items]                      
Weighted average interest rate of long-term debt, interest rate           2.80%   2.80%      
Weighted average maturity of long-term debt, at point in time           76 days          
Borrowings outstanding           $ 4,708,000,000   € 4,100   1,097,000,000 € 933
U.S. dollar-denominated commercial paper | Commercial paper                      
Debt Instrument [Line Items]                      
Borrowings outstanding           0          
364-Day Facility | Revolving credit facility                      
Debt Instrument [Line Items]                      
Line of credit facility         $ 5,000,000,000.0            
Borrowings outstanding           0          
Debt term         364 days            
Debt conversion fee equal to amount of principal outstanding, percentage         0.50%            
Commitment fee percentage         0.04%            
Consolidated Leverage Ratio to be maintained         0.65            
364-Day Facility | Revolving credit facility | Debt Rate, Condition Two                      
Debt Instrument [Line Items]                      
Debt instrument, basis spread on variable rate         1.00%            
364-Day Facility | Revolving credit facility | Fed funds rate                      
Debt Instrument [Line Items]                      
Debt instrument, basis spread on variable rate         0.05%            
364-Day Facility | Revolving credit facility | Secured Overnight Financing Rate (SOFR) | Debt Rate, Condition One                      
Debt Instrument [Line Items]                      
Debt instrument, basis spread on variable rate         1.00%            
364-Day Facility | Revolving credit facility | Minimum | Debt Rate, Condition Two                      
Debt Instrument [Line Items]                      
Debt instrument, basis spread on variable rate         0.00%            
364-Day Facility | Revolving credit facility | Minimum | Secured Overnight Financing Rate (SOFR)                      
Debt Instrument [Line Items]                      
Debt instrument, basis spread on variable rate         0.585%            
364-Day Facility | Revolving credit facility | Maximum | Debt Rate, Condition Two                      
Debt Instrument [Line Items]                      
Debt instrument, basis spread on variable rate         0.085%            
364-Day Facility | Revolving credit facility | Maximum | Secured Overnight Financing Rate (SOFR)                      
Debt Instrument [Line Items]                      
Debt instrument, basis spread on variable rate         1.085%            
2026 Biopharma Euronotes | Senior notes                      
Debt Instrument [Line Items]                      
Borrowings outstanding           0       1,469,000,000  
Aggregate principal amount | €               1,300 € 1,300   1,300
Total Masimo Financing Euronotes | Senior notes                      
Debt Instrument [Line Items]                      
Aggregate principal amount | €       € 3,000              
Proceeds from debt, net of issuance costs     $ 3,500,000,000 € 3,000              
Total Masimo Financing CHF Notes | Senior notes                      
Debt Instrument [Line Items]                      
Aggregate principal amount | SFr   SFr 2,383                  
Total Masimo Financing CHF Notes | Bonds                      
Debt Instrument [Line Items]                      
Proceeds from debt, net of issuance costs $ 3,000,000,000.0 SFr 2,400                  
2.1% senior unsecured notes due 9/30/2026 (€800 million) (the “2026 Euronotes”) (c) | Senior notes                      
Debt Instrument [Line Items]                      
Borrowings outstanding           $ 912,000,000       $ 940,000,000  
Aggregate principal amount | €               € 800     € 800
2.1% senior unsecured notes due 9/30/2026 (€800 million) (the “2026 Euronotes”) (c) | Senior notes | Subsequent Event                      
Debt Instrument [Line Items]                      
Aggregate principal amount | €             € 800